233 related articles for article (PubMed ID: 27926859)
1. Rapamycin Reverses Metabolic Deficits in Lamin A/C-Deficient Mice.
Liao CY; Anderson SS; Chicoine NH; Mayfield JR; Academia EC; Wilson JA; Pongkietisak C; Thompson MA; Lagmay EP; Miller DM; Hsu YM; McCormick MA; O'Leary MN; Kennedy BK
Cell Rep; 2016 Dec; 17(10):2542-2552. PubMed ID: 27926859
[TBL] [Abstract][Full Text] [Related]
2. Rapamycin reverses elevated mTORC1 signaling in lamin A/C-deficient mice, rescues cardiac and skeletal muscle function, and extends survival.
Ramos FJ; Chen SC; Garelick MG; Dai DF; Liao CY; Schreiber KH; MacKay VL; An EH; Strong R; Ladiges WC; Rabinovitch PS; Kaeberlein M; Kennedy BK
Sci Transl Med; 2012 Jul; 4(144):144ra103. PubMed ID: 22837538
[TBL] [Abstract][Full Text] [Related]
3. Grb10 promotes lipolysis and thermogenesis by phosphorylation-dependent feedback inhibition of mTORC1.
Liu M; Bai J; He S; Villarreal R; Hu D; Zhang C; Yang X; Liang H; Slaga TJ; Yu Y; Zhou Z; Blenis J; Scherer PE; Dong LQ; Liu F
Cell Metab; 2014 Jun; 19(6):967-80. PubMed ID: 24746805
[TBL] [Abstract][Full Text] [Related]
4. Rheb Inhibits Beiging of White Adipose Tissue via PDE4D5-Dependent Downregulation of the cAMP-PKA Signaling Pathway.
Meng W; Liang X; Chen H; Luo H; Bai J; Li G; Zhang Q; Xiao T; He S; Zhang Y; Xu Z; Xiao B; Liu M; Hu F; Liu F
Diabetes; 2017 May; 66(5):1198-1213. PubMed ID: 28242620
[TBL] [Abstract][Full Text] [Related]
5. Elucidating the role of Lkb1 and mTOR in adipose tissue.
Xu Z; You W; Wang F; Wang Y; Shan T
Adipocyte; 2019 Dec; 8(1):26-30. PubMed ID: 30318987
[TBL] [Abstract][Full Text] [Related]
6. Activation of mTORC1 is essential for β-adrenergic stimulation of adipose browning.
Liu D; Bordicchia M; Zhang C; Fang H; Wei W; Li JL; Guilherme A; Guntur K; Czech MP; Collins S
J Clin Invest; 2016 May; 126(5):1704-16. PubMed ID: 27018708
[TBL] [Abstract][Full Text] [Related]
7. Beneficial metabolic effects of rapamycin are associated with enhanced regulatory cells in diet-induced obese mice.
Makki K; Taront S; Molendi-Coste O; Bouchaert E; Neve B; Eury E; Lobbens S; Labalette M; Duez H; Staels B; Dombrowicz D; Froguel P; Wolowczuk I
PLoS One; 2014; 9(4):e92684. PubMed ID: 24710396
[TBL] [Abstract][Full Text] [Related]
8. mTOR Inhibition Prolongs Survival and Has Beneficial Effects on Heart Function After Onset of Lamin A/C Gene Mutation Cardiomyopathy in Mice.
Wu W; Jin Q; Östlund C; Tanji K; Shin JY; Han J; Leu CS; Kushner J; Worman HJ
Circ Heart Fail; 2024 Apr; 17(4):e011110. PubMed ID: 38567527
[TBL] [Abstract][Full Text] [Related]
9. The Cutting Edge: The Role of mTOR Signaling in Laminopathies.
Chiarini F; Evangelisti C; Cenni V; Fazio A; Paganelli F; Martelli AM; Lattanzi G
Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30781376
[TBL] [Abstract][Full Text] [Related]
10. Targeting of mTORC2 may have advantages over selective targeting of mTORC1 in the treatment of malignant pheochromocytoma.
Zhang X; Wang X; Xu T; Zhong S; Shen Z
Tumour Biol; 2015 Jul; 36(7):5273-81. PubMed ID: 25666752
[TBL] [Abstract][Full Text] [Related]
11. Elevated MTORC1 signaling and impaired autophagy.
Ramos FJ; Kaeberlein M; Kennedy BK
Autophagy; 2013 Jan; 9(1):108-9. PubMed ID: 23064282
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic inhibition of mTORC2 rescues the behavioral and neurophysiological abnormalities associated with Pten-deficiency.
Chen CJ; Sgritta M; Mays J; Zhou H; Lucero R; Park J; Wang IC; Park JH; Kaipparettu BA; Stoica L; Jafar-Nejad P; Rigo F; Chin J; Noebels JL; Costa-Mattioli M
Nat Med; 2019 Nov; 25(11):1684-1690. PubMed ID: 31636454
[TBL] [Abstract][Full Text] [Related]
13. The role of LMNA in adipose: a novel mouse model of lipodystrophy based on the Dunnigan-type familial partial lipodystrophy mutation.
Wojtanik KM; Edgemon K; Viswanadha S; Lindsey B; Haluzik M; Chen W; Poy G; Reitman M; Londos C
J Lipid Res; 2009 Jun; 50(6):1068-79. PubMed ID: 19201734
[TBL] [Abstract][Full Text] [Related]
14. Recent Advances in Adipose mTOR Signaling and Function: Therapeutic Prospects.
Cai H; Dong LQ; Liu F
Trends Pharmacol Sci; 2016 Apr; 37(4):303-317. PubMed ID: 26700098
[TBL] [Abstract][Full Text] [Related]
15. Reactivation of autophagy ameliorates LMNA cardiomyopathy.
Choi JC; Worman HJ
Autophagy; 2013 Jan; 9(1):110-1. PubMed ID: 23044536
[TBL] [Abstract][Full Text] [Related]
16. mTOR controls embryonic and adult myogenesis via mTORC1.
Rion N; Castets P; Lin S; Enderle L; Reinhard JR; Eickhorst C; Rüegg MA
Development; 2019 Apr; 146(7):. PubMed ID: 30872276
[TBL] [Abstract][Full Text] [Related]
17. UCP1 inhibition in Cidea-overexpressing mice is physiologically counteracted by brown adipose tissue hyperrecruitment.
Fischer AW; Shabalina IG; Mattsson CL; Abreu-Vieira G; Cannon B; Nedergaard J; Petrovic N
Am J Physiol Endocrinol Metab; 2017 Jan; 312(1):E72-E87. PubMed ID: 27923808
[TBL] [Abstract][Full Text] [Related]
18. Oxyresveratrol Increases Energy Expenditure through Foxo3a-Mediated Ucp1 Induction in High-Fat-Diet-Induced Obese Mice.
Choi JH; Song NJ; Lee AR; Lee DH; Seo MJ; Kim S; Chang SH; Yang DK; Hwang YJ; Hwang KA; Ha TS; Yun UJ; Park KW
Int J Mol Sci; 2018 Dec; 20(1):. PubMed ID: 30577593
[TBL] [Abstract][Full Text] [Related]
19. Sex- and tissue-specific changes in mTOR signaling with age in C57BL/6J mice.
Baar EL; Carbajal KA; Ong IM; Lamming DW
Aging Cell; 2016 Feb; 15(1):155-66. PubMed ID: 26695882
[TBL] [Abstract][Full Text] [Related]
20. Macrophage infiltration into obese adipose tissues suppresses the induction of UCP1 level in mice.
Sakamoto T; Nitta T; Maruno K; Yeh YS; Kuwata H; Tomita K; Goto T; Takahashi N; Kawada T
Am J Physiol Endocrinol Metab; 2016 Apr; 310(8):E676-E687. PubMed ID: 26884382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
